Top 31 Remegen investors
The most complete profiles first. Showing 31 of 31.
Albert ChaVerified
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareHospitalsWomen FoundedRoboticsPortfolio: Ossium Health, Aligos Therapeutics, Olema Oncology, Synapse Biomedical and 81 more
Verified email available
David BonitaVerified
Venture Capital, Private Equity Firm, Investor · United States
SeedSeries AHealth CareInvestment ManagementLife ScienceInformation Technology (IT)Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 93 more
Verified email available
Geoffrey HsuVerified
Venture Capital, Private Equity Firm, Investor · United States
SeedSeries AHealth CareInvestment ManagementLife ScienceInformation Technology (IT)Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more
Verified email available
Mahendra ShahVerified
Venture Capital, Private Equity Firm, Investor · United States
Series BHealth CareHospitalsWomen FoundedRoboticsPortfolio: Ossium Health, Aligos Therapeutics, Olema Oncology, Synapse Biomedical and 75 more
Verified email available
Nathan DauVerified
Venture Capital, Private Equity Firm, Investor · United States
Series BHealth CareHospitalsWomen FoundedRoboticsPortfolio: Ossium Health, Aligos Therapeutics, Olema Oncology, Synapse Biomedical and 75 more
Verified email available
Andy LinVerified
Venture Capital, Private Equity Firm · China
Health CareGeneticsLife ScienceEmerging MarketsPortfolio: InfiNovo, HYGEIA Healthcare Group, Phyplus, Immupeutics Medicine and 53 more
Verified email available
Fei ChenVerified
Venture Capital · China
Health CareGeneticsWomen FoundedLife SciencePortfolio: KSQ Therapeutics, xInnovent Biologics, Abbisko Therapeutics, Microtech Medical and 59 more
Contact details available
Jason ZhaoVerified
Private Equity Firm · China
Health CareGeneticsLife ScienceBiotechnologyPortfolio: InfiNovo, HYGEIA Healthcare Group, Phyplus, Immupeutics Medicine and 53 more
Verified email available
Jay GuVerified
Venture Capital, Private Equity Firm · China
Health CareGeneticsLife ScienceEmerging MarketsPortfolio: InfiNovo, HYGEIA Healthcare Group, Phyplus, Immupeutics Medicine and 53 more
Verified email available
Jonathan SilversteinVerified
Private Equity Firm · United States
Health CareLife ScienceInformation Technology (IT)MobilePortfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more
Verified email available
Jonathan WangVerified
Private Equity Firm · China
Health CareLife ScienceInformation Technology (IT)MobilePortfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more
Verified email available
Judith LiVerified
Venture Capital · Hong Kong
Health CareGeneticsWomen FoundedLife SciencePortfolio: KSQ Therapeutics, xInnovent Biologics, Abbisko Therapeutics, Microtech Medical and 59 more
Verified email available
Linda CaiVerified
Venture Capital, Private Equity Firm · China
Health CareGeneticsLife ScienceEmerging MarketsPortfolio: InfiNovo, HYGEIA Healthcare Group, Phyplus, Immupeutics Medicine and 53 more
Verified email available
Qi ZhuVerified
Venture Capital, Private Equity Firm · China
Health CareHospitalsWomen FoundedInvestment ManagementPortfolio: Ossium Health, Aligos Therapeutics, Olema Oncology, Synapse Biomedical and 75 more
Verified email available
Rishi GuptaVerified
Private Equity Firm · United States
Health CareInvestment ManagementLife ScienceInformation Technology (IT)Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more
Verified email available
Yi ShiVerified
Venture Capital · China
Health CareGeneticsWomen FoundedLife SciencePortfolio: KSQ Therapeutics, xInnovent Biologics, Abbisko Therapeutics, Microtech Medical and 59 more
Verified email available
Carter Neild
Venture Capital, Private Equity Firm, Investor · United States
SeedSeries AHealth CareInvestment ManagementLife ScienceInformation Technology (IT)Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more
Contact details available
Chau Khuong
Venture Capital, Private Equity Firm, Investor · United States
SeedSeries AHealth CareLife ScienceInformation Technology (IT)MobilePortfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Gennao Bio, Yisheng Biopharma and 89 more
Contact details available
Frank Kung
Venture Capital, Founder, Private Equity Firm · United States
Series BHealth CareHospitalsWomen FoundedInvestment ManagementPortfolio: Ossium Health, Aligos Therapeutics, Olema Oncology, Synapse Biomedical and 76 more
Contact details available
Scotland Stevens
Venture Capital, Private Equity Firm, Investor · United States
SeedSeries AHealth CareInvestment ManagementLife ScienceInformation Technology (IT)Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more
Contact details available
Anat Naschitz
Private Equity Firm · Israel
Health CareLife ScienceInformation Technology (IT)MobilePortfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more
Contact details available
Andrew Goldberg
Venture Capital, Private Equity Firm · United States
Health CareHospitalsWomen FoundedRoboticsPortfolio: Ossium Health, Aligos Therapeutics, Olema Oncology, Synapse Biomedical and 75 more
Contact details available
Brian Chi
Private Equity Firm · China
Health CareGeneticsLife ScienceBiotechnologyPortfolio: InfiNovo, HYGEIA Healthcare Group, Phyplus, Immupeutics Medicine and 53 more
Contact details available
Chengbin Li
Private Equity Firm · China
Health CareGeneticsLife ScienceBiotechnologyPortfolio: InfiNovo, HYGEIA Healthcare Group, Phyplus, Immupeutics Medicine and 53 more
Contact details available
Erez Chimovits
Private Equity Firm · Israel
Health CareInvestment ManagementLife ScienceInformation Technology (IT)Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more
Contact details available
Jieyu Zou
Venture Capital · China
Health CareGeneticsWomen FoundedInvestment ManagementPortfolio: KSQ Therapeutics, xInnovent Biologics, Abbisko Therapeutics, Microtech Medical and 59 more
Contact details available
Ling Su
Venture Capital · China
Health CareGeneticsWomen FoundedLife SciencePortfolio: KSQ Therapeutics, xInnovent Biologics, Abbisko Therapeutics, Microtech Medical and 59 more
Contact details available
Lisa Ye
Private Equity Firm · China
Health CareGeneticsLife ScienceBiotechnologyPortfolio: InfiNovo, HYGEIA Healthcare Group, Phyplus, Immupeutics Medicine and 53 more
Contact details available
Nina Feng
Venture Capital, Private Equity Firm · Taiwan
Health CareHospitalsWomen FoundedRoboticsPortfolio: Ossium Health, Aligos Therapeutics, Olema Oncology, Synapse Biomedical and 75 more
Contact details available
Roy Xie
Venture Capital, Private Equity Firm · China
Health CareGeneticsLife ScienceEmerging MarketsPortfolio: InfiNovo, HYGEIA Healthcare Group, Phyplus, Immupeutics Medicine and 53 more
Contact details available
Shan Fu
Venture Capital, Private Equity Firm · China
Health CareHospitalsWomen FoundedInvestment ManagementPortfolio: Ossium Health, Aligos Therapeutics, Olema Oncology, Synapse Biomedical and 75 more
Contact details available
By investment stage
By location
Related industries
Most-backed portfolio companies
Frequently asked questions
How many Remegen investors are on Angel Roster?
Angel Roster lists 31 Remegen investors. 15 of them (48%) include a verified email address.
What types of investors are they?
The most common investor types are Private Equity Firms (26), Venture Capital Firms (22) and Founder-Investors (1). An investor can have more than one type, for example an angel who is also a venture partner.
Which stages do Remegen investors invest in?
Among those that list a stage, the most common are Seed (6), Series A (5) and Series B (3).
Where are Remegen investors based?
Most are based in China (15), the United States (12) and Israel (2).
Which companies have Remegen investors backed?
The most-backed portfolio companies among them are Rongchang Pharmaceutical (23), Passage Bio (23), Terns Pharmaceuticals (23), Abbisko Therapeutics (23) and Gracell Biotechnologies (23).
How do I contact Remegen investors?
Create a free Angel Roster account to search and filter all 31, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.